Free CME from PeerView


Gynecology/Obstetrics CME

Credits: 0.75 CME / MOC
PVI, PeerView Institute for Medical Education
Upgrading the Treatment Algorithm for Advanced Ovarian Cancer: Expert Tips, Tools, and Patient Care Strategies for Making the Most of PARP Inhibitors Across the Disease Continuum
Linda R. Duska, MD, MPH / Debra L. Richardson, MD, FACS, FACOG
May 16, 2023
Credits: 1.5 CME / NCPD / ILNA / IPCE
PVI, PeerView Institute for Medical Education
Expert Nursing Insights on Personalized Care for Gynecologic Cancers: Educating and Supporting Patients on the Latest Therapeutic Approaches
Kimberly Halla, MSN, FNP-C
April 26, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Immunotherapy as a Treatment Cornerstone for Advanced Endometrial Cancer: Personalizing Patient Care
David M. O'Malley, MD
March 25, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Navigating Complex Decisions at the Intersection of Local and Systemic Management of Early Breast Cancer
Laura S. Dominici, MD, FACS
March 24, 2023
Credits: 1.5 CME / MOC / CC
PVI, PeerView Institute for Medical Education
A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer: Exploring the Biology and Updating Best Practices for Testing and Treatment
Stuart J. Schnitt, MD
March 13, 2023
Credits: 1.0 CME / CC
PVI, PeerView Institute for Medical Education
Refining Best Practices in Cancer Immunotherapy Biomarker Testing and Pathologic Response Assessment
Janis Taube, MD, MSc
March 02, 2023
Credits: 1.0 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
New Horizons for Advanced Endometrial Cancer Treatment: Utilizing Innovative Immunotherapies and Other Novel Approaches
Shannon N. Westin, MD, MPH
February 07, 2023
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Meeting the Imperative for Improved Cancer Screening Through Multi-Cancer Early Detection Testing: What’s My Role as an OB/GYN Provider?
Eric A. Klein, MD
December 15, 2022
Credits: 2.0 CME / MOC
PVI, PeerView Institute for Medical Education
Clarifying the Complexities of the Expanding Treatment Options for Advanced- and Early-Stage HR+/HER2- Breast Cancer
Erika Hamilton, MD
December 07, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal: Advancing Patient-Centered Care to Make the Most of Modern Targeted Treatments
Professor Peter Schmid, FRCP, MD, PhD
November 16, 2022
Credits: 1.0 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Breaking Down Barriers to Treatment Adherence and Persistence in HR+/HER2- Early Breast Cancer
Sara M. Tolaney, MD, MPH
October 17, 2022
Credits: 1.0 CME / NCPD / CPE
AGA Institute
An Exploration of Advances in the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation in a Unique Era of Patient Care: Incorporating an Individualized Approach to Help Your Patients Find Relief
Brooks D. Cash, MD, FACP, FACG, FASGE, AGAF, RFF
September 12, 2022
Credits: 0.5 CME / MOC / NCPD / IPCE
PVI, PeerView Institute for Medical Education
Harmonizing Interprofessional Care With Modern, Molecularly Informed, and Equitable Therapy for Patients With Advanced Endometrial Cancer: Lessons From a Gynecologic Cancer Center of Excellence
Ritu Salani, MD, MBA
August 30, 2022
Credits: 1.0 CME / MOC / NCPD / ILNA
PVI, PeerView Institute for Medical Education
Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment
Alexander Drilon, MD
August 16, 2022
Credits: 0.75 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Candid Conversations and Clinical Consults in Community Context: Practical Guidance for Integrating TROP2-Targeting ADCs Into Patient-Centric Breast Cancer Clinical Care
Aditya Bardia, MD, MPH
June 23, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Navigating the Shifting Treatment Paradigm in ER+/HER2- Breast Cancer: Harnessing Modern Treatment Options and the Expanding Evidence Base to Better Patient Care and Outcomes in Early and Advanced Disease
Aditya Bardia, MD, MPH
June 16, 2022
Medical Learning Institute, Inc.
Making Sense of the Evolving Treatment Landscape in Ovarian Cancer Care: Pharmacy Perspectives on PARP Inhibitor Therapy
Thomasina Morris, RPh, MHA, BCOP
May 06, 2022
Medical Learning Institute, Inc.
How to Harness Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HER2- Early Breast Cancer: New Goals and Better Tools to Close the Gaps
Erika Hamilton, MD
April 29, 2022
PVI, PeerView Institute for Medical Education
Tackling the Practicalities of Antibody–Drug Conjugate Therapy for Solid Tumors: Improving Clinical Care With HER2-, HER3-, and TROP2-Targeted Therapies
Linda Ahn, MSN, ANP-BC, AOCNP
April 28, 2022
Medical Learning Institute, Inc.
Expanding the Benefits and Refining the Role of Immune Checkpoint Inhibitors in the Treatment of Recurrent and Advanced Endometrial Cancer
Bhavana Pothuri, MD, MS
April 27, 2022
PVI, PeerView Institute for Medical Education
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvant Immunotherapy to Facilitate Progress in Early-Stage Cancers
Prof. Solange Peters, MD, PhD
April 10, 2022
Medical Learning Institute, Inc.
Applying Evidence to Practice in Postpartum Depression: Expert Guidance on Integrating Therapeutic Innovations and Shared Decision-Making Strategies to Optimize Patient Care
Kristina M. Deligiannidis, MD
April 08, 2022
Medical Learning Institute, Inc.
Expanding the Benefits of PARP Inhibitors to More Patients With Breast Cancer and Earlier Settings
Henry M. Kuerer, MD, PhD, FACS
April 08, 2022
PVI, PeerView Institute for Medical Education
Cancer Screening and Preventive Care for Transgender Individuals: Patient and Provider Perspectives on Best Practices and Special Considerations
Elizabeth Eaman, MD
April 01, 2022
Medical Learning Institute, Inc.
Recent Advances in the Management of Depressive Disorders: Preparing for a Shift in the Treatment Paradigm
Anita H. Clayton, MD
March 31, 2022
Medical Learning Institute, Inc.
Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors
Kurt A. Schalper, MD, PhD
March 23, 2022
Medical Learning Institute, Inc.
When Are PARP Inhibitors the Best Choice for Patients With Ovarian Cancer? Personalizing Therapeutic Selection Across the Disease Continuum
Bradley J. Monk, MD, FACS, FACOG
March 22, 2022
PVI, PeerView Institute for Medical Education
Translating Progress With Immunotherapies and Targeted Agents Into Improved Outcomes in Triple-Negative Breast Cancer: Surgical and Clinical Perspectives on Modern Multimodal Treatment Approaches
Henry M. Kuerer, MD, PhD, FACs / Heather L. McArthur, MD, MPH
March 12, 2022
PVI, PeerView Institute for Medical Education
Putting the Pieces Together: Would You Recognize Acute Hepatic Porphyria If You Saw It?
Herbert L. Bonkovsky, MD
February 25, 2022
Erika Hamilton, MD
Medical Learning Institute, Inc.
Expanding Treatment Options in ER+/HER2- Breast Cancer: Expert Perspectives on the Rapidly Emerging Role of SERDs, SERMs, and SERCAs, and the Practical Considerations of Leveraging Established and Innovative Therapies
Erika Hamilton, MD
January 19, 2022

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView